An official website of the United States government
Home
Name
CIA
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CIA
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
Name
Alternate Names
A-4942
Asta Z-4942
Cyfos#
Holoxan 1000
Ifex
Ifosfamid
Ifoxan
Iphosphamid
Iphosphamide
Iso-endoxan
Isofosfamide
Isophos-phamide
Isophosphamide
Mitoxana
MJF 9325
MJF-9325
Naxamide#
Z4942
Abbreviations
IFX
IPP
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
109724
Primary Site
Bladder
Cervical cancer
Ewing sarcoma
Head and Neck
Hodgkin lymphoma
Non-Hodgkin lymphoma
Soft tissue sarcoma, osteogenic sarcoma
Testicular cancer
Histology
None
Remarks
Antineoplastic with alkylating activity. FDA approved.
Coding
This drug should be coded
